Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Traditional Chinese medicine composition for pneumonia caused by 2019 novel coronavirus and application thereof

A coronavirus and composition technology, applied in drug combinations, antiviral agents, pharmaceutical formulations, etc., can solve the problems of weak virus inhibition, insufficient clinical treatment needs, insufficient understanding and understanding, etc. Novel effects of the formula

Active Publication Date: 2021-12-03
INST OF BASIC RES & CLINICAL MEDICINE CHINA ACAD OF CHINESE MEDICAL SCI
View PDF8 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, the new type of coronavirus pneumonia is a new disease after all, and doctors' understanding and understanding of the disease is not comprehensive enough
Some studies have pointed out that Lianhua Qingwen has a good therapeutic effect on the inflammation of patients with new coronary pneumonia, but the direct inhibitory effect on the virus is weak
In the case that the global new crown pneumonia epidemic has not been alleviated, the demand for clinical treatment has not been well met

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine composition for pneumonia caused by 2019 novel coronavirus and application thereof
  • Traditional Chinese medicine composition for pneumonia caused by 2019 novel coronavirus and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Example 1 A traditional Chinese medicine composition for pneumonia caused by 2019 novel coronavirus

[0038] The raw material of the described Chinese medicine composition of the present embodiment consists of (1 part=1kg):

[0039] 20 parts of Beibai Diancao, 15 parts of Banzhilian, 15 parts of Polygonum cuspidatum, 15 parts of honeysuckle, 10 parts of Nepeta, 10 parts of Desmodium, 10 parts of Forsythia, 10 parts of Verbena, 10 parts of Ligustrum lucidum, Epimedium 10 parts, aster 10 parts.

Embodiment 2

[0040] Example 2 A traditional Chinese medicine composition for pneumonia caused by 2019 novel coronavirus

[0041] The raw material of the described Chinese medicine composition of the present embodiment consists of (1 part=1kg):

[0042] 15 parts of Beibai Diancao, 12 parts of Banzhilian, 12 parts of Polygonum cuspidatum, 10 parts of honeysuckle, 10 parts of Nepeta, 10 parts of Desmodium, 10 parts of Forsythia, 10 parts of Verbena, 10 parts of Ligustrum lucidum, Epimedium 10 parts, aster 10 parts.

Embodiment 3

[0043] Example 3 A kind of traditional Chinese medicine composition for novel coronavirus pneumonia

[0044] The raw material of the described Chinese medicine composition of the present embodiment consists of (1 part=1kg):

[0045] 12 parts of Beibai Diancao, 10 parts of Banzhilian, 10 parts of Polygonum cuspidatum, 10 parts of honeysuckle, 8 parts of Nepeta, 8 parts of Desmodium, 8 parts of Forsythia, 8 parts of Verbena, 8 parts of Ligustrum lucidum, Epimedium 8 parts, aster 6 parts.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a traditional Chinese medicine composition for pneumonia caused by 2019 novel coronavirus and application thereof. The traditional Chinese medicine composition is prepared from the following medicinal materials in parts by weight: 1 to 20 parts of herba patriniae, 1 to 15 parts of herba scutellariae barbatae, 1 to 15 parts of rhizoma polygoni cuspidati, 1 to 15 parts of honeysuckle flowers, 1 to 10 parts of herba schizonepetae, 1 to 10 parts of herba lysimachiae, 1 to 10 parts of fructus forsythiae, 1 to 10 parts of herba verbenae, 1 to 10 parts of fructus ligustri lucidi, 1 to 10 parts of herba epimedii and 1 to 10 parts of radix asteris.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine and pharmacy, and in particular relates to a traditional Chinese medicine composition for pneumonia caused by 2019 novel coronavirus and its application. Background technique [0002] Corona Virus Disease 2019 (COVID-19), referred to as "New Coronary Pneumonia", refers to the pneumonia caused by the 2019 novel coronavirus (SARS-CoV-2) infection. [0003] The 2019 novel coronavirus is a new strain of coronavirus that has never been discovered before. The novel coronavirus pneumonia caused by it is an acute emerging infectious disease. As of May 2020, there have been more than 5 million confirmed cases of COVID-19 worldwide, and over 340,000 deaths. Once the new coronary pneumonia develops into a state of respiratory failure in the middle and late stages, the success rate of treatment will drop significantly. Therefore, it is most critical to prevent the progression of the di...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/85A61P31/14A61P11/00
CPCA61K36/84A61K36/539A61K36/704A61K36/355A61K36/538A61K36/185A61K36/53A61K36/634A61K36/85A61K36/638A61K36/296A61K36/28A61P31/14A61P11/00A61K2300/00Y02A50/30
Inventor 王忠王永炎刘琼
Owner INST OF BASIC RES & CLINICAL MEDICINE CHINA ACAD OF CHINESE MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com